Abstract
A number of novel 3-arylilidene and 3-arylimine-2-oxindole derivatives were synthesized, and their Src kinase inhibitory activities and antiproliferative activities were evaluated. Several compounds exhibited Src kinase inhibitory activitywith IC50 values in the range of 5.3 to 211.8 μM. Compound b11 in 3-arylimine-2-oxindoles showed IC50 values of 5.3 μM against Src kinase. Compounds a8, a20, a38, and b15 showed consistently>50% proliferation inhibition against all three cancer celllines at a concentration of 50 μM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
